Newsroom

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société biotechnologique pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir les pertes d'audition, annonce aujourd'hui les résultats du vote des résolutions présentées lors de son Assemblée générale mixte (AGM), tenue le 11 mai 2026 et leur mise à disposition dans la section dédiée du site internet de la Société. Toutes les résolutions recommandée...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced the results of resolutions presented at its Combined General Meeting (CGM), held on May 11, 2026, and made them available on the dedicated section of its website All resolutions recommended by the Board and submitted to the Combined General...

PARIS--(BUSINESS WIRE)--Regulatory News: Vitura (Paris:VTR): Solide dynamique locative avec des renouvellements majeurs Au cours du premier trimestre, 16 000 m² ont été renouvelés auprès de locataires de premier plan au sein d’Arcs de Seine à Boulogne-Billancourt. Ces transactions ont permis de porter la durée moyenne résiduelle des baux de cet actif à plus de sept années. Huawei, l’un des principaux fournisseurs mondiaux d’infrastructures de technologies de l’information et de la communication...

PARIS--(BUSINESS WIRE)--Regulatory News: Vitura (Paris:VTR): Strong rental momentum driven by major renewals During the first quarter, 16,000 sq.m were renewed with first-rate tenants at Arcs de Seine in Boulogne-Billancourt. These transactions have increased the average remaining lease term for the property to over seven years. Huawei, one of the world's leading telecommunications providers, extended its lease for a non-cancelable term of nine years. As part of an ambitious strategy to reposit...

MUNICH--(BUSINESS WIRE)--1Q 2026 Total business volume at 53.0 billion euros, an internal growth of 3.5 percent1. This was driven by a strong development in Property-Casualty and Asset Management Operating profit rises 6.6 percent and reaches a record level of 4.5 billion euros Shareholders’ core net income advances by 48.4 percent to 3.8 billion euros, impacted by the sale of the stakes in our Indian Joint Ventures. Underlying growth, which adjusts for the sale effects and offsetting measures,...

Marseille--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq: IPHA) (« Innate » ou la « Société ») annonce aujourd’hui son chiffre d’affaires et sa position de trésorerie pour les trois premiers mois de l’année 2026. « Au cours de ce premier trimestre, nous avons poursuivi une dynamique solide sur l’ensemble de nos produits cliniques prioritaires. Le recrutement dans la phase d’escalade de dose et les cohortes de backfill de l’étude de Phase 1 d’IPH4502 est en co...

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Abu Dhabi's Phoenix Group Partners with DC Max to Unlock $8 Billion European AI Data Center Opportunity, with Lyon, France as First Deployment...

NEW YORK & PARIS--(BUSINESS WIRE)--Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to revolutionize drug discovery and development, today announced an agreement with AstraZeneca to build biopharma agents as part of their three-year licensing of K Pro – Owkin’s AI Scientist for biopharma decision making. K Pro brings multimodal data and specialized biological agentic AI to each step of the value chain. Under the three-year licensing agreement, Owkin will lead the...

BUCHAREST, Romania--(BUSINESS WIRE)--An enterprise software startup whose platform has helped to modernize aviation infrastructure across Europe has raised more than $5.5 million in seed funding, highlighting growing demand for tools that can safely and speedily upgrade mission-critical systems. DesignVerse is an AI-based platform that builds and delivers complex enterprise software using an organization’s own documentation and internal rules, ensuring every system is built consistently across...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its business update and consolidated financial results for the quarter ending March 31, 2026. “We have continued to make solid progress across our priority clinical assets during the first quarter. We are approaching completion of enrollment in the Phase 1 dose escalation and backfill cohorts for IPH4502. In parallel, we have advanced the negotiati...